Featured Articles

Intermittent glucocorticoid treatment improves muscle metabolism via the PGC1/Lipin1 axis in an aging-related sarcopenia model

Journal: The Journal of clinical investigation2024Pubmed ID: 38702076
Product: [KO Validated] TTC11/FIS1 Rabbit mAb (A19666)
Gene: [KO Validated] TTC11/FIS1 Rabbit mAb
Gene ID: 51024
Species: Mus musculus
Application: WB
IF: 13.3

Intermittent glucocorticoid treatment improves muscle metabolism via the PGC1/Lipin1 axis in an aging-related sarcopenia model

Journal: The Journal of clinical investigation2024Pubmed ID: 38702076
Product: GOT2 Rabbit mAb (A19245)
Gene: GOT2 Rabbit mAb
Gene ID: 2806
Species: Mus musculus
Application: WB
IF: 13.3

Intermittent glucocorticoid treatment improves muscle metabolism via the PGC1/Lipin1 axis in an aging-related sarcopenia model

Journal: The Journal of clinical investigation2024Pubmed ID: 38702076
Product: Mitofusin 2 Rabbit mAb (A19678)
Gene: Mitofusin 2 Rabbit mAb
Gene ID: 9927
Species: Mus musculus
Application: WB
IF: 13.3

Intermittent glucocorticoid treatment improves muscle metabolism via the PGC1/Lipin1 axis in an aging-related sarcopenia model

Journal: The Journal of clinical investigation2024Pubmed ID: 38702076
Product: PGC1α Rabbit pAb (A12348)
Gene: PGC1 Rabbit pAb
Gene ID: 10891
Species: Mus musculus
Application: WB
IF: 13.3

Intermittent glucocorticoid treatment improves muscle metabolism via the PGC1/Lipin1 axis in an aging-related sarcopenia model

Journal: The Journal of clinical investigation2024Pubmed ID: 38702076
Product: 2X SYBR Green Fast qPCR Mix No Rox (RK21200)
Gene: 2X SYBR Green Fast qPCR Mix No Rox
Gene ID:
Species: Mus musculus
Application: RT-qPCR
IF: 13.3

Intermittent glucocorticoid treatment improves muscle metabolism via the PGC1/Lipin1 axis in an aging-related sarcopenia model

Journal: The Journal of clinical investigation2024Pubmed ID: 38702076
Product: Glucocorticoid Receptor Rabbit pAb (A2164)
Gene: Glucocorticoid Receptor Rabbit pAb
Gene ID: 2908
Species: Mus musculus
Application: ChIP, WB
IF: 13.3

Intermittent glucocorticoid treatment improves muscle metabolism via the PGC1/Lipin1 axis in an aging-related sarcopenia model

Journal: The Journal of clinical investigation2024Pubmed ID: 38702076
Product: GLUD1 Rabbit pAb (A7631)
Gene: GLUD1 Rabbit pAb
Gene ID: 2746
Species: Mus musculus
Application: WB
IF: 13.3

Intermittent glucocorticoid treatment improves muscle metabolism via the PGC1/Lipin1 axis in an aging-related sarcopenia model

Journal: The Journal of clinical investigation2024Pubmed ID: 38702076
Product: GAPDH Rabbit pAb (AC027)
Gene: GAPDH Rabbit pAb
Gene ID: 2597
Species: Mus musculus
Application: WB
IF: 13.3

Myostatin regulates energy homeostasis through autocrine-and paracrine-mediated microenvironment communications

Journal: The Journal of clinical investigation2024Pubmed ID: 38889010
Product: β-Tubulin Rabbit pAb (AC008)
Gene: -Tubulin Rabbit pAb
Gene ID: 203068
Species: Mus musculus
Application: WB
IF: 13.3

METTL14-mediated m6A epitranscriptomic modification contributes to chemotherapy-induced neuropathic pain by stabilizing GluN2A expression via IGF2BP2

Journal: The Journal of clinical investigation2024Pubmed ID: 38319733
Product: METTL14 Rabbit pAb (A8530)
Gene: METTL14 Rabbit pAb
Gene ID: 57721
Species: Homo sapiens
Application: WB
IF: 13.3

METTL14-mediated m6A epitranscriptomic modification contributes to chemotherapy-induced neuropathic pain by stabilizing GluN2A expression via IGF2BP2

Journal: The Journal of clinical investigation2024Pubmed ID: 38319733
Product: METTL14 Rabbit pAb (A8530)
Gene: METTL14 Rabbit pAb
Gene ID: 57721
Species: Rattus norvegicus
Application: IF
IF: 13.3

METTL14-mediated m6A epitranscriptomic modification contributes to chemotherapy-induced neuropathic pain by stabilizing GluN2A expression via IGF2BP2

Journal: The Journal of clinical investigation2024Pubmed ID: 38319733
Product: NMDAR1 Rabbit pAb (A7677)
Gene: NMDAR1 Rabbit pAb
Gene ID: 2902
Species: Homo sapiens
Application: WB
IF: 13.3

METTL14-mediated m6A epitranscriptomic modification contributes to chemotherapy-induced neuropathic pain by stabilizing GluN2A expression via IGF2BP2

Journal: The Journal of clinical investigation2024Pubmed ID: 38319733
Product: IGF2BP1/IMP1 Rabbit pAb (A1517)
Gene: IGF2BP1/IMP1 Rabbit pAb
Gene ID: 10642
Species: Homo sapiens
Application: WB
IF: 13.3

METTL14-mediated m6A epitranscriptomic modification contributes to chemotherapy-induced neuropathic pain by stabilizing GluN2A expression via IGF2BP2

Journal: The Journal of clinical investigation2024Pubmed ID: 38319733
Product: [KD Validated] METTL14 Rabbit mAb (A24396)
Gene: [KD Validated] METTL14 Rabbit mAb
Gene ID: 57721
Species: Homo sapiens
Application: IP
IF: 13.3

METTL14-mediated m6A epitranscriptomic modification contributes to chemotherapy-induced neuropathic pain by stabilizing GluN2A expression via IGF2BP2

Journal: The Journal of clinical investigation2024Pubmed ID: 38319733
Product: β-Tubulin Rabbit pAb (AC008)
Gene: -Tubulin Rabbit pAb
Gene ID: 203068
Species: Homo sapiens
Application: WB
IF: 13.3